Preferred first-tier test for developmental delay, multiple anomalies, and autism-spectrum disorders. Testing is performed on peripheral blood.
Genomic Microarray (Oligo-SNP Array)
Collect: Green (Sodium Heparin). Peripheral blood required. Also acceptable: Lavender (K2EDTA).
New York State Clients: Green (Sodium Heparin) AND Lavender (K2EDTA).
Transport 5 mL whole blood. (Min: 1 mL)
New York State Clients: Transport 4 mL whole blood in the original Green (Sodium Heparin) tube and 3 mL whole blood in the original Lavender (K2EDTA) tube. (Min: 2 mL Sodium Heparin and 2 mL EDTA).
Ambient: 48 hours; Refrigerated: 72 hours; Frozen: Unacceptable
New York State Clients: Ambient: 1 week; Refrigerated: 1 week; Frozen: Unacceptable
Refer to report.
Compliance Statement C: For human genetic inheritable conditions and mutations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online.
This test must be ordered using a Cytogenetic test request form 43097 or through your ARUP interface. Please submit the Genomic Microarray Patient Clinical Information Form with the electronic packing list (https://ltd.aruplab.com/Tests/Pdf/76).
|Component Test Code*||Component Chart Name||LOINC|
|2003415||Cytogenomic SNP Microarray||62375-1|
|2003416||EER Cytogenomic SNP Microarray||11526-1|
- Array CGH
- Array Comparative Genomic Hybridization
- Chromosomal Microarray
- Comparative Genomic Hybridization
- Congenital Array
- Constitutional Array
- Genomic Microarray
- Molecular Karyotype
- Oligo Array
- Oligonucleotide Array
- Single-nucleotide-polymorphism (SNP) array
- Targeted Array
- Whole Genome Array